Welcome to the Clinical Criteria Page

This page provides the clinical criteria documents for all injectable, infused, or implanted prescription drugs and therapies covered under the medical benefit. The effective dates for using these documents for clinical reviews are communicated through the Provider notification process.
 
To determine if a code requires authorization, use the NY Prior Authorization lookup tool or WNY Precertification lookup tool
 
The New York Medicaid state-specific clinical criteria information is alphabetized below. Not all drugs requiring authorization have New York Medicaid State specific criteria. If a code requires authorization and the clinical criteria document is not found in the list below, please utilize the following link for additional criteria.Clinical Criteria
 

New York Specific Policies

Clinical Criteria
Associated Medications (as applicable) Document Number Coding
Gonadotropin Releasing Hormone Analogs for the Treatment of Non-Oncologic Indications Fensolvi, Lupron Depot, Lupron Depot-Ped, Lupaneta Pack, Supprelin LA 12 month implant, Synarel Nasal Spray, Triptodur, Vantas, Zoladex CC-0061 - NY J1675, J1950, J1951, J3315, J3316, J9202, J9217 J9225, J9226, S9560
Hyaluronan Injections Durolane, GenVisc 850, Hyalgan, Supartz, Hymovis, Euflexxa, Orthovisc, Synvisc, Synvisc-One, Gel-One, Monovisc, Gel-Syn, trivisc, synojoynt, Triluron, Visco-3 CC-0006 - NY J7318, J7320, J7321, J7322, J7323, J7324, J7325, J7326, J7327, J7328, J7329, J7331, J7332, J7333
Amondys CC-0189 - NY J1426
Exondys CC-0044 - NY J1428
Viltepso CC-0172 - NY J1427
Vyondys CC-0152 - NY J1429
Gonadotropin Releasing Hormone Analogs for the Treatment of Oncologic Indications Lupron Depot 3.75, Zoladex, Lupron, leuprolide, goserelin CC-0102 - NY J1950, J9202, J9218, S9560
Gonadotropin Releasing Hormone Analogs for the Treatment of Oncologic Indications Lupron Depot 3.75, Lupron Depot 3-month 11.25, Lupron. leuprolide, goserelin CC-0102 - NY J1950, J9218, S9560
Gonadotropin Releasing Hormone Analogs for the Treatment of Oncologic Indications Trelstar, Trelstar LA, Firmagon, Zoladex, Eligard, Lupron Depot 7.5, Lupron Depot 22.5 mg (3-month), Lupron Depot 30 mg (4-month), Lupron Depot 45 mg (6-month), Lupron, Vantas, Camcevi, leuprolide, goserelin CC-0102 - NY J3315, J9155, J9202, J9217, J9218, J9225, J1952, S9560
Gonadotropin Releasing Hormone Analogs for the Treatment of Oncologic Indications histrelin acetate, Lupron Depot 3.75, Trelstar, Trelstar LA, Firmagon, Zoladex, Eligard, Lupron Depot, Lupron CC-0102 - NY J1675, J1950, J3315, J9155, J9202, J9217, J9218
Gonadotropin Releasing Hormone Analogs for the Treatment of Oncologic Indications Eligard 7.5 mg (1 Month), Eligard 22.5 mg (3 Month), Lupron Depot 7.5 mg (1 Month), Lupron Depot 22.5 mg (3 Month), leuprolide, goserelin CC-0102 - NY J9217, S9560


(Note: in the case of a clinical criteria document being listed on both sites, please utilize those listed directly above.)
 
If you have questions or feedback, please contact druglist@carelon.com.